Temafloxacin voluntary withdrawal: concerns about multicenter testing and postmarketing surveillance.
Rapp
R P
RP
D000890:Anti-Infective Agents; D002986:Clinical Trials as Topic; D016903:Drug Monitoring; D024841:Fluoroquinolones; D006801:Humans; D015337:Multicenter Studies as Topic; D011358:Product Surveillance, Postmarketing; D015363:Quinolones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C054745:temafloxacin